Thu.Nov 28, 2024

article thumbnail

Advancing Vaccine Development for RSV and hMPV: Overcoming Challenges With Pre-Fusion F Protein Stability

Pharmacy Times

Researchers developed a method to stabilize respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) fusion (F) proteins, advancing potential vaccines for both viruses.

Vaccines 121
article thumbnail

FDA probing cancer cases with Bluebird's CALD gene therapy

pharmaphorum

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's Skysona gene therapy for neurological disease CALD.

FDA 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Recent Intravenous Immunoglobulin Administration Can Lead to Serum Protein Electrophoresis Misdiagnosis

Pharmacy Times

Knowledge of recent intravenous immunoglobulin (IVIG) administration in patients receiving the common laboratory test can help inform misdiagnosis.

118
118
article thumbnail

Grifols slides as Brookfield pulls out of takeover talks

pharmaphorum

Brookfield has said it is withdrawing from negotiations to take over Grifols, sparking a slump in the Spanish pharma group's shares.

105
105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Q&A: A Closer Look at the Current State of Biosimilars in the Drug Market

Drug Topics

Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.

98
article thumbnail

Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat

Pharmaceutical Technology

The US Food and Drug Administration has declined to approve Applied Therapeutics’ govorestat for classic galactosemia.

FDA 98

More Trending

article thumbnail

CervoMed’s stock rises as FDA grants orphan drug status to dementia drug

Pharmaceutical Technology

There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.

FDA 96
article thumbnail

Applied Tx craters as FDA rejects lead product candidate

pharmaphorum

Applied Therapeutics plummets after the FDA turns down its marketing application for govorestat as a treatment for galactosaemia

FDA 97
article thumbnail

The EU AI Act: will regulation drive life science innovation away from Europe?

European Pharmaceutical Review

When the General Data Protection Regulation (GDPR) 1 came into effect in 2018, this appeared to accelerate the migration out of Europe for pharmaceutical clinical trials. This was not so much due to non-compliance but stemmed from regulatory ambiguity. As the EU now sets its sights on the regulation of artificial intelligence (AI) through the EU Artificial Intelligence Act (EU AI Act), 2 similar questions arise regarding the implementation and enforcement of the regulation.

article thumbnail

Understanding the Risks of Polypharmacy

Pharmacy Times

Using multiple physicians or pharmacists can result in a lack of coordinated care, missed medication interactions, and overlooked contraindications.

81
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Diabetes Roundup: Depression Increases Risk, Key Things to Know about Insulin Icodec

Drug Topics

Catch up on important diabetes news from November 2024.

76
article thumbnail

Fun Fact: A Chemical Found in Turkey Might Contribute to Post-Thanksgiving Drowsiness

Pharmacy Times

Tryptophan, found in turkey and other foods, affects serotonin and melatonin production.

73
article thumbnail

Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks

Pharmaceutical Technology

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial infarction (MI).

59
article thumbnail

How AI and Data Analytics Are Transforming the PBM Industry: A Look at Predictive Modeling, Risk Stratification, and Personalized Care

Pharmacy Times

Rising health care costs and the complex nature of medication management have prompted PBMs to adopt AI tools to enhance patient outcomes, streamline claims processes, reduce waste, and design smarter, data-driven health plans.

65
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Kronos Bio announces interim CEO and workforce cuts of 83%

Pharmaceutical Technology

Kronos Bio has announced the appointment of Deborah Knobelman as president and interim chief executive officer, effective 3 December.

52
article thumbnail

Designing personalised digital experiences that engage healthcare professionals

pharmaphorum

Designing personalised digital experiences for healthcare professionals (HCPs) involves collaboration between digital designers and data experts. Learn how to engage HCPs effectively with tailored digital solutions.

52
article thumbnail

Advanz Pharma’s liver disease drug pulled from European market after court hearing

Pharmaceutical Technology

This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024.

52
article thumbnail

Pharma Pulse 11/28/24: Solving Clinical Technology Challenges with Integration & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Green Transition

Pharmaceutical Technology

The relationship between climate change and infectious disease is raising new questions for pharmaceutical and clinical leaders.

52
article thumbnail

Pharma Pulse 11/28/24: Nov. 27 Passed—What Does That Mean for DSCSA? & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

LEAP HR: Life Sciences West

pharmaphorum

Join us in San Francisco, CA this April for LEAP HR: Life Sciences West to network with 200+ senior HR leaders

52
article thumbnail

EC approves GSK’s Menveo vaccine presentation for IMD

Pharmaceutical Technology

The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).

article thumbnail

UK grants promising innovative medicine status to CIDP drug

Pharma Times

Therapy for autoimmune disorder shows potential

43
article thumbnail

Study finds AZ's benralizumab a 'game-changer' in asthma

pharmaphorum

Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if it was used to treat acute asthma attacks

40
article thumbnail

New injection offers hope for asthma and COPD attacks

Pharma Times

Injection significantly reduces need for further treatment

41
article thumbnail

Trump agency nominations show pharma industry as divided as US

Pharmaceutical Technology

Confirmation of Trump's nominations for appointments is not yet assured and the Senate will vote to approve them early in 2025.

102
102
article thumbnail

Final joint guidance on chronic asthma overhauls pharmacological recommendations

Hospital Pharmacy Europe

Long-awaited joint UK guidelines for chronic asthma have been finalised, overhauling diagnosis and treatment recommendations in an effort to better manage the condition in primary care and reduce pressure on hospitals. The final chronic asthma guidance from the National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) is designed to support clinicians in making accurate diagnoses, promoting good practice, a

article thumbnail

Trump 2.0 spells global change in pharmaceutical regulation, funding and investment

Pharmaceutical Technology

Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.

52